Atlas FDA

MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY

FDA premarket approval P040044/S038 · decided 2011-07-21

Approval details

PMA number
P040044
Supplement
S038
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
MYNX VASCULAR CLOSURE DEVICE PRODUCT FAMILY
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2011-05-27
Decision date
2011-07-21
Days to decision
55 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
APPROVAL FOR A CONTRACT STERILIZATION SITE, BEAMONE, LLC LOCATED IN MOUNTAIN VIEW, CALIFORNIA.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.